BIB

ProShares Ultra NASDAQ Biotechnology

$75.48

+0.00%

Market closed. Last update: 10:58 PM ET

📎 Investment Objective

The BIB ETF seeks to provide investment results that correspond to twice (2x) the daily performance of the NASDAQ Biotechnology Index.

Overview

ETF tracking ProShares Ultra NASDAQ Biotechnology

Category Technology

Issuer ProShares

Inception Date 2010-04-08

Market Cap $73.2M

Average Volume N/A

Dividend Yield 1.16%

52-Week Range $36.99 - $76.07

VWAP $75.82

Performance

Loading performance data...

Price Chart

Investment Summary

📎 Investment Objective

The BIB ETF seeks to provide investment results that correspond to twice (2x) the daily performance of the NASDAQ Biotechnology Index.

🎯 Investment Strategy

The fund uses a combination of financial instruments, such as derivatives, to achieve its 2x daily leveraged exposure to the NASDAQ Biotechnology Index. It does not hold the actual securities in the index directly.

✨ Key Features

Provides 2x the daily performance of the NASDAQ Biotechnology Index
Utilizes derivatives and other financial instruments to achieve its leveraged exposure
Resets its leverage daily, which can lead to compounding effects over longer holding periods
Has a very low expense ratio of 0.00%

⚠️ Primary Risks

Significant daily volatility and potential for losses, especially over longer time frames
Leverage risk, as the fund's performance can deviate substantially from the underlying index over time
Liquidity risk, as the fund may have lower trading volume compared to the broader market
Concentration risk, as the fund is focused solely on the biotechnology sector

👤 Best For

The BIB ETF is best suited for experienced, risk-tolerant investors seeking short-term, leveraged exposure to the biotechnology sector. It is not recommended for long-term buy-and-hold investors due to the compounding effects of daily rebalancing.